New Roche Development Center In Shanghai To Focus on Metabolic Diseases, Tumors
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Roche formally opened its Pharma Development Center in China (PDCC) Oct. 29 in Shanghai, the Swiss company's first comprehensive drug development center in the Asia-Pacific region, outside of Japan
You may also be interested in...
Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams On Seeking More Innovation In China And Korea: An Interview With PharmAsia News (Part 1 of 2)
Roche recently expanded its investment in innovation in Asia by opening its fourth Global Partnering office in Shanghai. Roche Global Licensing Director Stella Xu and Business Development Director Frank Grams sat down with PharmAsia News' Shanghai Bureau to talk about the mission of the newly established partnering site and Roche's partnering strategies in Asia.
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).